MicroRNAs differentially expressed in pancreatic diseases and uses thereof

Details for Australian Patent Application No. 2007299828 (hide)

Owner Asuragen, Inc.

Inventors Szafranska, Anna E.; Davison, Tim; Labourier, Emmanuel; John, Jeremy

Agent Pizzeys

Pub. Number AU-A-2007299828

PCT Pub. Number WO2008/036765

Priority 60/826,173 19.09.06 US

Filing date 19 September 2007

Wipo publication date 27 March 2008

International Classifications

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

Event Publications

23 April 2009 PCT application entered the National Phase

  PCT publication WO2008/036765 Priority application(s): WO2008/036765

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007299843-Optimized antibodies that target HM1.24

2007299822-Spiro benzazepines as vasopressin antagonists